Get the tools used by (smart)2 investors.

Nuo Therapeutics, Inc.OTCPK:AURX

United States / Healthcare / Biotechnology

Join now and get access to the full platform

Exchange Data

Hide this widget
1.37 USD
Price
-0.26 (-16.00%)
Day change
0.25 - 1.93
52-week range

Summary of Nuo Therapeutics, Inc.

Hide this widget

Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness th...

Dec 31, 2024
Latest Report
Filings

Price History

Chart Gallery
Hide this widget
Loading chart...

Data Explorer

Hide this widget

Peer Benchmarks

Hide this widget
  AURX Peers Sector
Market Cap
76.082 M47.834 M66.88 M
Price % of 52 Week High
NA46.4%61.3%
Dividend Yield
0.0%0.0%0.0%
Shareholder Yield
-2.7%-14.0%-0.6%
1 Year Price Total Return
71.3%-40.6%-11.8%
Beta (5 Year)
-1,008.031.330.64

In the News

Hide this widget

Data could not be retrieved

Finbox Fair Value

Hide this widget
What is Finbox Fair Value?
A stock's fair value is its real or underlying intrinsic worth.
Read more about Finbox's Fair Value methodology.
USD
Average
Upside
Uncertainty
You need an account to use this feature
Sign Up
Or
Log In

Financial Health

Health Details
Hide this widget
-
Financial Health information is currently not available for Nuo Therapeutics.

Financial Models for Nuo Therapeutics, Inc.

Model Gallery
Hide this widget

Historical Financials

Full Financials
Hide this widget
(presentment in millions)Trailing Twelve MonthsFiscal Quarters
Period EndingDec-22Dec-23Dec-24Dec-23Dec-24
Income Statement
Revenue0.110.611.370.200.39
Operating Income(3.32)(3.17)(2.46)(0.65)(0.63)
Net Profit(3.17)(3.17)(2.32)(0.65)(0.50)
Diluted EPS-0.079-0.075-0.051-0.015-0.011
EBITDA(3.31)(3.15)(2.43)(0.65)(0.62)
Balance Sheet
Cash & ST Invest.2.050.930.280.930.28
Current Assets2.631.560.841.560.84
Total Assets3.051.881.191.881.19
Current Liabilities0.600.670.580.670.58
Total Liabilities0.860.840.680.840.68
Total Equity2.191.040.511.040.51
Total Debt0.340.260.160.260.16
Cash Flow Statement
Cash Flow Operations(3.71)(3.17)(2.23)(0.67)(0.49)
Cash From Investing(0.06)(0.01)(0.15)0.000.00
Cash From Financing4.462.001.740.960.09
Free Cash Flow(3.77)(3.18)(2.39)(0.67)(0.49)

Analyst Notes

April 29, 2025
Hide this widget
    All rights reserved. Terms Of Use